Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis

被引:57
|
作者
Kaur, Sukhbir [1 ]
Kaur, Tejinder [1 ]
Garg, Nishma [1 ]
Mukherjee, Sudeshna [1 ]
Raina, Puneet [1 ]
Athokpam, Voleentina [1 ]
机构
[1] Panjab Univ, Dept Zool, Parasitol Lab, Chandigarh 160014, India
关键词
D O I
10.1007/s00436-008-1150-x
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
A potential vaccine candidate for visceral leishmaniasis should favour the development of CD4(+) Th1 type of immune response which is further dependent on the dose of antigen and the route of inoculation. The present study was carried out to check the effective dose (low, medium and high) and route (subcutaneous, intradermal, intraperitoneal and intracardiac) of inoculation for the development of a CD4(+) Th1 type of immune response in BALB/c mice. The parasite load was found to be the lowest in mice inoculated with low dose of promastigotes through the subcutaneous route, followed by intradermal, intraperitoneal and intracardiac routes. A reduced parasite load in mice inoculated through subcutaneous route was found to be associated with heightened DTH responses. The IgG2a levels were found to be the maximum in case of mice inoculated with the low dose of promastigotes through subcutaneous route followed by intradermal and intraperitoneal routes. In contrast, mice inoculated with high dose of promastigotes through the intracardiac route showed increased levels of IgG1. Low-dose inoculation with subcutaneous route elicited maximum IFN-gamma levels, which points towards the generation of Th1 response. Maximum IL-4 and IL-10 levels were detected in high-dose inoculation through intracardiac route suggesting the development of Th2 response. In conclusion, inoculation through subcutaneous route with low dose of live whole parasite antigen evokes a strong Th1 response in BALB/c mice.
引用
收藏
页码:1413 / 1419
页数:7
相关论文
共 50 条
  • [31] The initial immune response during experimental cysticercosis is of the mixed Th1/Th2 type
    Toenjes, SA
    Kuhn, RE
    PARASITOLOGY RESEARCH, 2003, 89 (05) : 407 - 413
  • [32] 卵巢早衰患者外周血CD4+、Th1/Th2细胞分布研究
    杨桂艳
    王一理
    曹缵
    孙李旭
    生殖医学杂志, 1998, (04) : 36 - 39
  • [33] In Vivo CD4+ T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm
    Ruterbusch, Mikel
    Pruner, Kurt B.
    Shehata, Laila
    Pepper, Marion
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 38, 2020, 38 : 705 - 725
  • [34] CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy
    Xia, N
    Zhou, SX
    Liang, YZ
    Xiao, CQ
    Shen, HL
    Pan, HL
    Deng, HM
    Wang, NZ
    Li, QDQ
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (05) : 911 - 916
  • [35] In vitro maturation of naive human CD4+ T lymphocytes into Th1, Th2 effectors
    Delespesse, G
    Demeure, CE
    Yang, LP
    Ohshima, Y
    Byun, DG
    Shu, U
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 113 (1-3) : 157 - 159
  • [36] Expression of Chemokine Receptors on Th1/Th2 CD4+ Lymphocytes in Patients with Multiple Sclerosis
    Andalib, Alireza
    Doulabi, Hassan
    Najafi, Mohamadreza
    Tazhibi, Mehdi
    Rezaie, Abbas
    IRANIAN JOURNAL OF IMMUNOLOGY, 2011, 8 (01) : 1 - 10
  • [37] Effect of methotrexate on Th1 and Th2 immune responses in mice
    Yamaki, K
    Uchida, H
    Harada, Y
    Li, XJ
    Yanagisawa, R
    Takano, H
    Hayashi, H
    Taneda, S
    Mori, Y
    Yoshino, S
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (12) : 1661 - 1666
  • [38] Reprogrammed fibrocytes induce a mixed Th1/Th2 cytokine response of naïve CD4+ T cells
    Abelardo Medina
    Aziz Ghahary
    Molecular and Cellular Biochemistry, 2011, 346 : 89 - 94
  • [39] Human CD4+ CD25+ CD127hi cells and the Th1/Th2 phenotype
    Narsale, Aditi
    Moya, Rosita
    Davies, Joanna Davida
    CLINICAL IMMUNOLOGY, 2018, 188 : 103 - 112
  • [40] Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors
    Delespesse, G
    Yang, LP
    Ohshima, Y
    Demeure, C
    Shu, U
    Byun, DG
    Sarfati, M
    VACCINE, 1998, 16 (14-15) : 1415 - 1419